|
||||||||||||||||||||||||||
| SEC Info℠ | | | Home | | | Search | | | My Interests | | | Help | | | Sign In | | | Please Sign In | |||||||
|
||||||||||||||||||||||||||
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/26/11 Clorox Co/DE 10-K 6/30/11 116:16M DG3/FA |
Document/Exhibit Description Pages Size
1: 10-K Annual Report HTML 315K
2: EX-10.18 Amendment No.1 to the Clorox Company Amended and HTML 39K
Restated
3: EX-10.29 The Clorox Company 2011 Nonqualified Deferred HTML 120K
Compensation Plan
4: EX-21.1 Subsidiaries List HTML 55K
5: EX-23.1 Consent of Independent Registered Public HTML 33K
Accounting Firm
9: EX-99.1 Management's Discussion and Analysis of Financial HTML 1.01M
Condition and Results
10: EX-99.2 Valuation and Qualifying Accounts and Reserves HTML 53K
11: EX-99.3 Reconciliation of Economic Profit HTML 59K
12: EX-99.4 Calculation of Return on Invested Capital HTML 44K
6: EX-31.1 Certification of the Chief Executive Officer of HTML 39K
the Clorox Company
7: EX-31.2 Certification of the Chief Financial Officer of HTML 39K
the Clorox Company
8: EX-32.1 Certification of the Chief Executive Officer and HTML 34K
Chief Financial Officer
30: R1 Document and Entity Information HTML 59K
102: R2 Consolidated Statements of Earnings HTML 144K
21: R3 Consolidated Balance Sheets HTML 138K
22: R4 Consolidated Balance Sheets (Parenthetical) HTML 58K
88: R5 Consolidated Statements of Stockholders' (Deficit) HTML 109K
Equity
53: R6 Consolidated Statements of Stockholders' (Deficit) HTML 43K
Equity (Parenthetical)
95: R7 Consolidated Statements of Cash Flows HTML 186K
42: R8 Summary of Significant Accounting Policies HTML 85K
55: R9 Discontinued Operations HTML 55K
63: R10 Businesses Acquired HTML 43K
80: R11 Restructuring and Asset Impairment HTML 44K
35: R12 Inventories, Net HTML 43K
51: R13 Other Current Assets HTML 46K
44: R14 Property, Plant and Equipment, Net HTML 44K
47: R15 Goodwill, Trademarks and Other Intangible Assets HTML 80K
96: R16 Accrued Liabilities HTML 50K
41: R17 Debt HTML 54K
74: R18 Financial Instruments and Fair Value Measurements HTML 77K
45: R19 Other Liabilities HTML 41K
101: R20 Other Contingencies HTML 37K
82: R21 Stockholders' (Deficit) Equity HTML 82K
89: R22 Earnings Per Share HTML 47K
27: R23 Share-Based Compensation Plans HTML 181K
92: R24 Leases and Other Commitments HTML 41K
40: R25 Other (Income) Expense, Net HTML 79K
32: R26 Income Taxes HTML 115K
36: R27 Employee Benefit Plans HTML 485K
66: R28 Segment Reporting HTML 116K
87: R29 Guarantees HTML 34K
73: R30 Unaudited Quarterly Data HTML 104K
57: R31 Valuation and Qualifying Accounts and Reserves HTML 70K
50: R32 Summary of Significant Accounting Policies HTML 148K
(Policy)
71: R33 Summary of Significant Accounting Policies HTML 43K
(Tables)
100: R34 Discontinued Operations (Tables) HTML 46K
43: R35 Restructuring and Asset Impairment (Tables) HTML 41K
103: R36 Inventories, Net (Tables) HTML 38K
116: R37 Other Current Assets (Tables) HTML 45K
38: R38 Property, Plant and Equipment, Net (Tables) HTML 42K
85: R39 Goodwill, Trademarks and Other Intangible Assets HTML 73K
(Tables)
56: R40 Accrued Liabilities (Tables) HTML 49K
72: R41 Debt (Tables) HTML 55K
65: R42 Financial Instruments and Fair Value Measurements HTML 67K
(Tables)
37: R43 Other Liabilities (Tables) HTML 37K
90: R44 Stockholders' (Deficit) Equity (Tables) HTML 61K
113: R45 Earnings Per Share (Tables) HTML 48K
114: R46 Share-Based Compensation Plans (Tables) HTML 167K
33: R47 Other (Income) Expense, Net (Tables) HTML 74K
31: R48 Income Taxes (Tables) HTML 113K
109: R49 Employee Benefit Plans (Tables) HTML 469K
20: R50 Segment Reporting (Tables) HTML 105K
61: R51 Unaudited Quarterly Data (Tables) HTML 102K
52: R52 Valuation and Qualifying Accounts and Reserves HTML 69K
(Tables)
24: R53 Summary of Significant Accounting Policies HTML 84K
(Details)
115: R54 Discontinued Operations (Details) HTML 98K
97: R55 Businesses Acquired (Details) HTML 52K
75: R56 Restructuring and Asset Impairment (Details) HTML 58K
110: R57 Inventories, Net (Details) HTML 62K
59: R58 Other Current Assets (Details) HTML 45K
98: R59 Property, Plant and Equipment, Net (Details) HTML 63K
60: R60 Goodwill, Trademarks and Other Intangible Assets HTML 57K
(Narrative) (Details)
79: R61 Goodwill, Trademarks and Other Intangible Assets HTML 55K
(Schedule of Goodwill) (Details)
70: R62 Goodwill, Trademarks and Other Intangible Assets HTML 57K
(Schedule of Intangible Assets, Excluding
Goodwill) (Details)
84: R63 Accrued Liabilities (Details) HTML 51K
62: R64 Debt (Details) HTML 101K
83: R65 Financial Instruments and Fair Value Measurements HTML 110K
(Details)
67: R66 Other Liabilities (Details) HTML 48K
111: R67 Other Contingencies (Details) HTML 39K
94: R68 Stockholders' (Deficit) Equity (Details) HTML 113K
99: R69 Earnings Per Share (Details) HTML 76K
86: R70 Share-Based Compensation Plans (Narrative) HTML 108K
(Details)
23: R71 Share-Based Compensation Plans (Compensation Cost HTML 40K
and Related Income Tax Benefit) (Details)
93: R72 Share-Based Compensation Plans (Assumptions HTML 67K
Utilized in the Valuation in Calculating the
Compensation Expense for Stock Options Granted)
(Details)
46: R73 Share-Based Compensation Plans (Summary of Options HTML 73K
Outstanding Under the Plans and Activity during
the Year) (Details)
77: R74 Share-Based Compensation Plans (Summary of Status HTML 67K
of Restricted and Performance Stock Awards)
(Details)
107: R75 Leases and Other Commitments (Details) HTML 81K
64: R76 Other (Income) Expense, Net (Details) HTML 62K
34: R77 Income Taxes (Narrative) (Details) HTML 69K
69: R78 Income Taxes (Provision for Income Taxes by Tax HTML 84K
Jurisdiction and Domestic and Foreign Earnings
before Taxes) (Details)
104: R79 Income Taxes (Effective Income Tax Rate HTML 59K
Reconciliation) (Details)
28: R80 Income Taxes (Components of Net Deferred Tax HTML 91K
Assets) (Details)
76: R81 Income Taxes (Deferred Tax Assets and Unrecognized HTML 58K
Tax Benefits) (Details)
19: R82 Employee Benefit Plans (Narrative) (Details) HTML 69K
54: R83 Employee Benefit Plans (Summarized Information for HTML 111K
Defined Benefit Retirement Income and Healthcare
Plans) (Details)
25: R84 Employee Benefit Plans (Information for Retirement HTML 42K
Income Plans with Accumulated Benefit Obligation
in Excess of Plan Assets) (Details)
49: R85 Employee Benefit Plans (Components of the Net Cost HTML 54K
of Retirement Income and Health Care Plans)
(Details)
81: R86 Employee Benefit Plans (Items Not Recognized as a HTML 47K
Component of Post Retirement Expense) (Details)
68: R87 Employee Benefit Plans (Net Actuarial Loss (Gain) HTML 37K
and Prior Service Cost (Benefit) Activity Recorded
in Accumulated Other Comprehensive Loss (Income))
(Details)
48: R88 Employee Benefit Plans (Weighted-Average HTML 41K
Assumptions Used to Estimate the Net Periodic
Pension and Other Postretirement Benefit Costs)
(Details)
26: R89 Employee Benefit Plans (Expected Benefit Payments) HTML 49K
(Details)
78: R90 Employee Benefit Plans (Target Allocations and HTML 37K
Weighted Average Asset Allocations) (Details)
105: R91 Employee Benefit Plans (Assets Carried at Fair HTML 48K
Value) (Details)
91: R92 Segment Reporting (Details) HTML 171K
58: R93 Guarantees (Details) HTML 33K
39: R94 Unaudited Quarterly Data (Details) HTML 111K
112: R95 Valuation and Qualifying Accounts and Reserves HTML 46K
(Details)
106: XML IDEA XML File -- Filing Summary XML 177K
108: EXCEL IDEA Workbook of Financial Reports (.xls) XLS 2.97M
13: EX-101.INS XBRL Instance -- clx-20110630 XML 4.08M
17: EX-101.CAL XBRL Calculations -- clx-20110630_cal XML 256K
18: EX-101.DEF XBRL Definitions -- clx-20110630_def XML 689K
16: EX-101.LAB XBRL Labels -- clx-20110630_lab XML 1.96M
15: EX-101.PRE XBRL Presentations -- clx-20110630_pre XML 1.33M
14: EX-101.SCH XBRL Schema -- clx-20110630 XSD 303K
29: ZIP XBRL Zipped Folder -- 0001206774-11-001954-xbrl Zip 270K
|
I, Daniel J. Heinrich, certify that:
|
||||
| 1. | I have reviewed this annual report on Form 10-K of The Clorox Company; | |||
| 2. | Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; | |||
| 3. | Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; | |||
| 4. | The registrant’s other certifying officer and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and 15d-15(e)) and internal control over financial reporting (as defined in Exchange Act Rules 13a-15(f) and 15d-15(f)) for the registrant and have: | |||
| a) | designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared; | |||
| b) | designed such internal control over financial reporting, or caused such internal control over financial reporting to be designed under our supervision, to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles; | |||
| c) | evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and | |||
| d) | disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting. | |||
| 5. | The registrant’s other certifying officer and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions): | |||
| a) | all significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and | |||
| b) | any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal control over financial reporting. | |||
| /s/ Daniel J. Heinrich |
| Daniel J. Heinrich |
| Executive Vice President - Chief Financial Officer |
As Of Filer Filing For·On·As Docs:Size Issuer Filing Agent 8/10/23 Clorox Co./DE 10-K 6/30/23 133:15M 8/10/22 Clorox Co./DE 10-K 6/30/22 129:15M 8/10/21 Clorox Co./DE 10-K 6/30/21 131:16M 8/13/20 Clorox Co./DE 10-K 6/30/20 133:19M |